BRCA2 and cancer: Germline heterozygous mutations in BRCA1, BRCA2, and PALB2 were found in eight children with a spectrum of cancers including leukemia, CNS tumors, neuroblastoma, osteosarcoma, and rhabdomyosarcoma (Table 1).